Laboratory News and Research

RSS

Exposure to nanoparticles can play major role in development of cardiovascular diseases

Nanoparticles, extremely tiny particles measured in billionths of a meter, are increasingly everywhere, and especially in biomedical products. Their toxicity has been researched in general terms, but now a team of Israeli scientists has for the first time found that exposure nanoparticles (NPs) of silicon dioxide (SiO2) can play a major role in the development of cardiovascular diseases when the NP cross tissue and cellular barriers and also find their way into the circulatory system.

8 Jan 2015

Scientists discover potential solution to antibiotic resistance

A newly developed technique for screening microbes has led to the discovery of a powerful new antibiotic that can easily kill severe infections in mice, without causing side effects.

8 Jan 2015

Findings could accelerate development of prebiotic medicines for bowel problems, autoimmune diseases

Bacteria that have evolved to eat their way through yeast in the human gut could inform the development of new treatments for people suffering from bowel diseases.

8 Jan 2015

Canadian Blood Services, OPSEU reach tentative agreement to support employees in Ontario

Today, Canadian Blood Services announced that it has reached a tentative agreement with the Ontario Public Service Employees Union, representing its support employees in Ontario.

8 Jan 2015

Fast-track diagnostics releases CE-labelled Real-time PCR kit to detect Zaire Ebolavirus

Fast-track diagnostics, a global leader in the design, development and manufacture of infectious disease detection kits, has released a CE labelled Real-time PCR kit for the detection of the Zaire Ebolavirus – the strain responsible for the current outbreak in West Africa.

8 Jan 2015

Research findings could lead to new drug design for neurological diseases

A new intermediate step and unexpected enzymatic activity in a metabolic pathway in the body, which could lead to new drug design for psychiatric and neurodegenerative diseases, has been discovered by researchers at Georgia State University.

8 Jan 2015

Using HIV drugs to treat AMD: an interview with Dr Mark Young

NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth.

7 Jan 2015

New Horses and Hope campaign launched to raise $1 million for cancer screening mobile unit

Kentucky First Lady Jane Beshear today, along with representatives from the Kentucky Cancer Program, the University of Louisville's James Graham Brown Cancer Center and KentuckyOne Health, launched a new Horses and Hope campaign to raise $1 million for a mobile unit to provide free or significantly reduced cost cancer screenings to underserved populations across Kentucky.

7 Jan 2015

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent.

7 Jan 2015

Novel drug delivery technique uses graphene to deliver two anticancer drugs sequentially to cancer cells

An international team of researchers has developed a drug delivery technique that utilizes graphene strips as "flying carpets" to deliver two anticancer drugs sequentially to cancer cells, with each drug targeting the distinct part of the cell where it will be most effective. The technique was found to perform better than either drug in isolation when tested in a mouse model targeting a human lung cancer tumor.

7 Jan 2015

Real-time RT-PCR TaqMan assay helps differentiate active pulmonary TB from LTBI

One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI). Neither the tuberculin skin test (TST) nor interferon-gamma release assays (IGRAs) are capable of distinguishing active from latent infection or predicting the chance of reactivation.

7 Jan 2015

Elsevier assumes publication of Neoplasia and Translational Oncology journals

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, has announced that it has acquired Neoplasia Press Inc. and assumes publication of its flagship journals, Neoplasia and Translational Oncology. These peer-reviewed, open access journals are now published by Elsevier under the Neoplasia Press imprint.

6 Jan 2015

University of Limerick offers Leaving Certificate Biology Practical Sessions for secondary school students

The Department of Life Sciences at the University of Limerick are welcoming over 400 Leaving Certificate Biology students from all over Munster into their state-of-the-art laboratories this week.

6 Jan 2015

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

You can’t see it, hear it or smell it, and it’s constantly changing: but despite that, Australia’s nuclear scientists have figured out how to more accurately measure the unit of activity for radionuclides, the Becquerel (Bq).

6 Jan 2015

New findings may lay groundwork of novel treatment for people with Huntington's disease

By adjusting the levels of a key signaling protein, researchers improved motor function and brain abnormalities in experimental animals with a form of Huntington's disease, a severe neurodegenerative disorder.

5 Jan 2015

Neurological testing accessibility and affordability: an interview with Dr Joseph Higgins

Neurological disorders with genetic causes can be very difficult to diagnose without reliable, clinically relevant tests tailored to specific phenotypes.

From Quest Diagnostics 5 Jan 2015

MiMedx pleased with FDA Draft Guidance on Minimal Manipulation of HCT/Ps

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, commented on the Draft Guidance for Industry on Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products ("HCT/Ps") that the Food and Drug Administration ("FDA") published for comment on December 23, 2014.

31 Dec 2014

LIBD announces significant advances in identifying causes of schizophrenia, brain disorders

The Lieber Institute for Brain Development (LIBD) announces significant advances in identifying the causes of schizophrenia and related developmental brain disorders and translating these findings into new treatment strategies.

31 Dec 2014

NCI-designated Cancer Centers: An important source of care for cancer patients

You may have heard about National Cancer Institute-designated Cancer Centers. Perhaps there is even one in your city. NCI-designated Cancer Centers are often located at well-known, academic institutions, such as the Mayo Clinic, and are an important source of care for cancer patients.

31 Dec 2014

New therapeutic approach shows potential for treating cancer

Case Western Reserve researchers have identified a two-pronged therapeutic approach that shows great potential for weakening and then defeating cancer cells.

31 Dec 2014

Laboratory News and Research

Exposure to nanoparticles can play major role in development of cardiovascular diseases

Scientists discover potential solution to antibiotic resistance

Findings could accelerate development of prebiotic medicines for bowel problems, autoimmune diseases

Canadian Blood Services, OPSEU reach tentative agreement to support employees in Ontario

Fast-track diagnostics releases CE-labelled Real-time PCR kit to detect Zaire Ebolavirus

Research findings could lead to new drug design for neurological diseases

Using HIV drugs to treat AMD: an interview with Dr Mark Young

New Horses and Hope campaign launched to raise $1 million for cancer screening mobile unit

Researchers examine ischemic complications in patients who receive flow-diverting stents

Novel drug delivery technique uses graphene to deliver two anticancer drugs sequentially to cancer cells

Real-time RT-PCR TaqMan assay helps differentiate active pulmonary TB from LTBI

Elsevier assumes publication of Neoplasia and Translational Oncology journals

University of Limerick offers Leaving Certificate Biology Practical Sessions for secondary school students

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

New findings may lay groundwork of novel treatment for people with Huntington's disease

Neurological testing accessibility and affordability: an interview with Dr Joseph Higgins

MiMedx pleased with FDA Draft Guidance on Minimal Manipulation of HCT/Ps

LIBD announces significant advances in identifying causes of schizophrenia, brain disorders

NCI-designated Cancer Centers: An important source of care for cancer patients

New therapeutic approach shows potential for treating cancer

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics